Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis

Current Rheumatology Reports
Wendy MyersAlice Gottlieb

Abstract

Psoriasis and psoriatic arthritis are chronic inflammatory diseases that significantly affect patients' quality of life. Not only do these diseases impact patients' physical well-being, but also detrimentally affect their life socially and psychologically. There are many different patterns of skin and joint involvement. Understanding the pathogenesis of these diseases has evolved greatly in the past few decades. It is now understood that psoriasis and psoriatic arthritis are T cell mediated disorders. A number of proinflammatory cytokines have been suggested as playing a role in the disease mechanism, such as tumor necrosis factor-alpha and interferon-gamma. Other important factors proposed in the pathogenesis of these diseases include the role of genetics and environmental factors. New immunomodulating therapies, which are being developed as our understanding of the involvement of innate and adaptive immunity advances, will provide patients with safer, more effective, long-term, management options.

References

Aug 1, 1983·Journal of the American Academy of Dermatology·D M BuntinE W Rosenberg
Dec 1, 1993·Molecular & General Genetics : MGG·T KarhunenP L Suominen
May 1, 1996·Journal of the American Academy of Dermatology·M S GreenM G Lebwohl
Sep 18, 1999·Archives of Dermatology·B J Nickoloff
Apr 18, 2000·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·B P PetersM A Gill
May 18, 2000·Primary Care·G S Drew
Feb 24, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·M A Gupta, A K Gupta
Mar 17, 2001·The British Journal of Dermatology·S E Cockayne, A G Messenger
Jun 26, 2001·Clinical and Experimental Dermatology·U Fearon, D J Veale
Jul 28, 2001·The New England Journal of Medicine·R D Granstein
Nov 14, 2001·American Journal of Clinical Dermatology·P C van de Kerkhof, M E Franssen
Nov 14, 2001·Dermatologic Clinics·A B Gottlieb
Jan 5, 2002·Journal of the American Academy of Dermatology·James G Krueger
Mar 20, 2002·The British Journal of Dermatology·R J ChalmersC E Griffiths
May 22, 2002·Archives of Dermatology·Prashant SingriKenneth B Gordon
Jun 14, 2002·Journal of the American Academy of Dermatology·Carlos FerrándizJoan A Smandía
Oct 2, 2002·Acta Dermato-venereologica·Bhushan KumarInderjeet Kaur
Nov 8, 2002·Drugs·John Brockbank, Dafna Gladman
Dec 17, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Alice B Gottlieb, Jan D Bos
Dec 21, 2002·International Journal of Dermatology·Don MehrabiCalvin O McCall
Mar 26, 2003·International Journal of Dermatology·Hassan GaladariMark Lebwohl
Apr 11, 2003·Lancet·Mark Lebwohl
Aug 2, 2003·Journal of the American Academy of Dermatology·Stephanie L Mehlis, Kenneth B Gordon
Nov 25, 2003·The New England Journal of Medicine·Craig L LeonardiUNKNOWN Etanercept Psoriasis Study Group

❮ Previous
Next ❯

Citations

Jun 1, 2006·American Journal of Clinical Dermatology·Babu M Medi, Jagdish Singh
May 13, 2010·The Open Cardiovascular Medicine Journal·Mustafa Yildiz
Nov 13, 2007·European Journal of Radiology·C Zuhal ErdemSezen Gulec
Sep 16, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·J C PrinzB Freundlich
Sep 18, 2010·Clinical Science·Giovanni MonteleoneAntonio Costanzo
Nov 28, 2012·Autoimmunity Reviews·Maria Sole ChimentiRoberto Perricone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.